Skip to Content

VG Life Sciences Inc VGLS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VGLS is trading at a 64% discount.
Price
$0.00
Fair Value
$7.72
Uncertainty
Extreme
1-Star Price
$7.33
5-Star Price
$5.36
Economic Moat
Rth
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VGLS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$10,788.32
Volume/Avg
7.0 Mil / 31.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

VG Life Sciences Inc is a biotechnology company. It is engaged in the research and development of therapeutic and diagnostic pharmaceutical and medical products.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
1

Valuation

Metric
VGLS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VGLS
Quick Ratio
0.00
Current Ratio
0.01
Interest Coverage
−1.10
Quick Ratio
VGLS

Profitability

Metric
VGLS
Return on Assets (Normalized)
−369.55%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
VGLS
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRVmpbh$550.4 Bil
VRTX
Vertex Pharmaceuticals IncSfdjlz$111.8 Bil
REGN
Regeneron Pharmaceuticals IncBqlfc$107.9 Bil
MRNA
Moderna IncJvk$36.3 Bil
ARGX
argenx SE ADRLqj$22.1 Bil
BNTX
BioNTech SE ADRWdwf$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncFfrqhb$19.2 Bil
BMRN
Biomarin Pharmaceutical IncKjqcy$16.4 Bil
RPRX
Royalty Pharma PLC Class ATrzhbd$13.4 Bil
INCY
Incyte CorpHzwly$13.3 Bil

Sponsor Center